Biología Celular
Departamento
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (9)
2021
-
Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma
Cancer Medicine, Vol. 10, Núm. 21, pp. 7585-7592
2020
-
LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity
Cancer Letters, Vol. 474, pp. 1-14
2018
-
EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma
International Journal of Cancer, Vol. 143, Núm. 5, pp. 1188-1201
2017
-
DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1
Cancer Letters, Vol. 386, pp. 196-207
-
DNA methylation profiling opens a new phase in the search of targeted therapy against Ewing sarcoma
Pharmacogenomics, Vol. 18, Núm. 14, pp. 1307-1309
-
Improved selectivity and cytotoxic effects of irinotecan via liposomal delivery: A comparative study on Hs68 and HeLa cells
European Journal of Pharmaceutical Sciences, Vol. 109, pp. 65-77
2016
-
Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway
Oncotarget, Vol. 7, Núm. 35, pp. 56889-56903
2015
-
The importance of being dead: Cell death mechanisms assessment in anti-sarcoma therapy
Frontiers in Oncology, Vol. 5, Núm. APR
2014
-
Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth
Oncotarget, Vol. 5, Núm. 20, pp. 9744-9755